# CSL Plasma Inc. – FDA Inspection, Apr 6, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/f77ec7b9-22b9-4eab-8e0e-cf3ac9206039
Source feed: FDA_Inspections

> FDA inspection 1202780 of CSL Plasma Inc., April 06, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202780
- Company Name: CSL Plasma Inc.
- Inspection Date: 2023-04-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1234986 - 2024-05-17
- FDA Inspection 1029107 - 2017-08-18
- FDA Inspection 931544 - 2015-06-23
- FDA Inspection 826490 - 2013-04-04
- FDA Inspection 725725 - 2011-05-20

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)

Company: https://www.keypedia.com/companies/csl-plasma-inc/07d83451-b79c-4107-a33a-0fcdb53e40e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d